IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Altitude Crest Partners Inc.

Q1 2024 Holdings

Filed 2024-05-14 | 30 holdings | $233.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Legend Biotech Corp(LEGN)SPONSORED ADS52490G102$36.6M652,73215.7%
Danaher Corporation(DHR)COM235851102$27.1M108,70011.6%
Bridgebio Pharma Inc(BBIO)COM10806X102$18.9M612,0608.1%
Stevanato Group S P A(STVN)ORD SHST9224W109$17.7M550,0007.6%
Apellis Pharmaceuticals Inc(APLS)COM03753U106$16.9M287,2777.2%
Thermo Fisher Scientific Inc(TMO)COM883556102$10.7M18,4004.6%
Arrivent Biopharma Inc(AVBP)COM04272N102$9.9M555,5554.2%
Structure Therapeutics Inc(GPCR)SPONSORED ADS86366E106$8.8M205,1663.8%
Kiniksa Pharmaceuticals LTDCOM CL AG5269C101$7.9M400,4413.4%
Janux Therapeutics Inc(JANX)COM47103J105$7.3M193,3003.1%
ELI Lilly & Co(LLY)COM532457108$7.2M9,2003.1%
Biohaven LTD(BHVN)COMG1110E107$6.5M118,3802.8%
Immunome Inc(IMNM)COM45257U108$6.5M262,2842.8%
Springworks Therapeutics IncCOM85205L107$6.3M128,8422.7%
Geron Corp(GERN)COM374163103$5.1M1,531,4002.2%
Icon PLC(ICLR)SHSG4705A100$5.0M14,8002.1%
Merus N VCOMN5749R100$4.9M109,8372.1%
Roivant Sciences LTD(ROIV)SHSG76279101$4.8M454,7662.1%
Denali Therapeutics Inc(DNLI)COM24823R105$4.3M209,6131.8%
Corbus Pharmaceuticals Hldgs(CRBP)COM NEW21833P301$4.1M103,7031.7%
Agios Pharmaceuticals Inc(AGIO)COM00847X104$3.3M113,1001.4%
DAY One Biopharmaceuticals I(DAWN)COM23954D109$3.2M195,4971.4%
Aligos Therapeutics IncCOM01626L105$2.8M2,844,6811.2%
Engene Holdings Inc(ENGN)COM29286M105$2.0M120,2890.9%
Applied Therapeutics Inc(APLT)COM03828A101$1.8M259,7000.8%
Zymeworks Inc(ZYME)COM98985Y108$1.5M145,5810.7%
Metagenomi Inc(MGX)COM59102M104$1.4M133,3330.6%
Tourmaline BIO Inc(TRML)COM89157D105$1.1M47,4000.5%
Alnylam Pharmaceuticals Inc(ALNY)COM02043Q107$29.9K2000.0%
Surrozen Inc(SRZNW)*W EXP 08/01/20386889P117$12.5K384,5730.0%